Mafosfamide enhances interleukin-2-generated human effector cell cytotoxic activity against K562 myeloid leukaemia cells.

Suppr

超能文献

作者信息

Hassan H T

机构信息

Department of Haematology and Oncology, University of Hanover Medical School, Germany.

出版信息

Med Oncol. 1994;11(3-4):135-6. doi: 10.1007/BF02999862.

DOI:10.1007/BF02999862

PMID:7633833

Abstract

摘要

相似文献

Mafosfamide enhances interleukin-2-generated human effector cell cytotoxic activity against K562 myeloid leukaemia cells.

Med Oncol. 1994;11(3-4):135-6. doi: 10.1007/BF02999862.

Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide.用马磷酰胺增强荷P815肿瘤宿主小鼠脾脏中细胞毒性T淋巴细胞的生长。

Cancer Immunol Immunother. 1992;35(2):119-26. doi: 10.1007/BF01741859.

Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes.低剂量氮杂磷三环类化合物对人淋巴细胞自然杀伤活性的影响。

Cancer Immunol Immunother. 1989;29(2):151-3. doi: 10.1007/BF00199291.

Heparin enhances generation of natural killer activity in vitro.肝素在体外增强自然杀伤活性的产生。

Arch Immunol Ther Exp (Warsz). 1994;42(1):73-6.

ASTA-Z 7557 impairs human natural killer (NK) cell activity.

Leuk Res. 1996 Feb;20(2):169-74. doi: 10.1016/0145-2126(95)00142-5.

Agar capillary clonogenic microassays for cellular immunocytotoxic activities in human leukaemia and lymphoma.用于检测人类白血病和淋巴瘤细胞免疫细胞毒性活性的琼脂毛细管克隆形成微量分析

Leuk Lymphoma. 1993 Mar;9(4-5):305-13. doi: 10.3109/10428199309148527.

Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide.用马磷酰胺清除白血病后进行骨髓放疗及移植，对微小残留病成功进行过继性免疫治疗。

Cancer Immunol Immunother. 1990;32(1):71-4. doi: 10.1007/BF01741728.

Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.急性淋巴细胞白血病患者原代克隆形成性母细胞对活化环磷酰胺即马磷酰胺的敏感性。

Leuk Lymphoma. 1994 May;13(5-6):417-28. doi: 10.3109/10428199409049631.

Cyclophosphamide enhances anti-tumor effect of wild-type p53-specific CTL.环磷酰胺增强野生型p53特异性细胞毒性T淋巴细胞的抗肿瘤作用。

Int J Cancer. 2000 Jul 15;87(2):253-60. doi: 10.1002/1097-0215(20000715)87:2<253::aid-ijc17>3.0.co;2-a.

Anti-tumor effect of human lymphocytes and interleukin-2.人淋巴细胞和白细胞介素-2的抗肿瘤作用。

J Pak Med Assoc. 1993 Mar;43(3):45-9.

本文引用的文献

Leuk Lymphoma. 1993 Mar;9(4-5):305-13. doi: 10.3109/10428199309148527.

Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected].低剂量环磷酰胺与低剂量静脉注射白细胞介素-2治疗播散性黑色素瘤的有效性及耐受性[校正后]

J Clin Oncol. 1988 Mar;6(3):409-24. doi: 10.1200/JCO.1988.6.3.409.

Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models.低剂量环磷酰胺和马磷酰胺在两种动物肿瘤模型中增强宿主抗肿瘤免疫力

Cancer Immunol Immunother. 1989;28(3):179-84. doi: 10.1007/BF00204986.

Triple combination of retinoic acid + low concentration of cytosine arabinoside + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture.

Hematol Oncol. 1989 Nov-Dec;7(6):429-40. doi: 10.1002/hon.2900070606.

Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes.低剂量氮杂磷三环类化合物对人淋巴细胞自然杀伤活性的影响。

Cancer Immunol Immunother. 1989;29(2):151-3. doi: 10.1007/BF00199291.

Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation.

Blood. 1990 Sep 15;76(6):1092-7.

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.白细胞介素2可预防移植物抗宿主病，同时保留同种异体T细胞的移植物抗白血病效应。

Proc Natl Acad Sci U S A. 1990 Aug;87(15):5633-7. doi: 10.1073/pnas.87.15.5633.

Pharmacological-mediated purging with mafosfamide in acute and chronic myeloid leukemias. The Italian Study Group.

Prog Clin Biol Res. 1990;333:21-36; discussion 37-8.

Lymphokine-activated killer (LAK) cell purging of bone marrow.骨髓的淋巴因子激活杀伤细胞（LAK细胞）清除法

Prog Clin Biol Res. 1990;333:125-35; discussion 136-7.

Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group.急性淋巴细胞白血病的自体骨髓移植：用马磷酰胺控制残留病并用环孢素诱导同基因移植物抗宿主病。意大利马磷酰胺研究组

Bone Marrow Transplant. 1990 Jul;6 Suppl 1:76-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验